1 / 7

Fourth International Conference

Mobile Phones. - Is There A Health Risk?. Fourth International Conference. 9th - 10th November 1999, London. Mobile Phones. - Is There A Health Risk?. Day 1: Current Status of Scientific Knowledge Chairman: Gerd Friedrich, Managing Director Forschungsgemeinschaft Funk, Germany. Session1.

morty
Télécharger la présentation

Fourth International Conference

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mobile Phones - Is There A Health Risk? Fourth International Conference 9th - 10th November 1999, London

  2. Mobile Phones - Is There A Health Risk? Day 1: Current Status of Scientific Knowledge Chairman: Gerd Friedrich, Managing Director Forschungsgemeinschaft Funk, Germany Session1. Biological Effects of RF Radiation Session2. Dosimetry and Standards Session3. The Research Agenda Session4. The Role of the Media

  3. Mobile Phones - Is There A Health Risk? Session1. Biological Effects of RF Radiation Biological Effects of Radiofrequency Radiation James Lin, Professor of Bioengineering, University of Illinois, USA Epidemiological Studies Patricia Mckinney, University of Leeds, UK Cancer-Related Animal Studies Päivi Heikkinen, Department of Environmental Sciences, University of Kuopio, Finland Provocation and Behaviour Studies Zenon Sienkiewicz, National Radiological Protection Board, UK Human Physiological and Cognitive Studies Alan Preece, Department of Medical Physics, University of Bristol, UK In-Vitro Studies Isabelle Lagroye, Assistant Professor, Bioelectromagnetics Laboratory, University of Bordeaux, France

  4. Mobile Phones - Is There A Health Risk? Session2. Dosimetry and Standards Determination of RF Exposure Levels From Handsets Joe Wiart, France Telekom CNET, France Determination of RF Exposure Levels from Basestations György Thuróczy, National Research Institute for Radiobiology and Radiohygiene, Hungary Standards and Compliance Testing Paolo Bernardi, Department of Electrical Engineering, University of Rome „La Sapienza“, Italy Thermal and RF Modelling of Cellular Phones Jan Lagendijk, Head of Radiation Oncology Physics, University Medical Centre Utrecht, Holland

  5. Mobile Phones - Is There A Health Risk? Session3. The Research Agenda Priorities and Co-ordination for 2003 and 2004 Evaluations Anthony Muc, World Health Organization, Switzerland Research topics in the Fifth Framework Programme Arne Wennberg, Chairman, National Institute for Working Life, Sweden, Chairman, COST244bis Project Interpreting the Science Sheila Johnston, PhD Experimental Psychology & Neuroscience, UK Video - Its in the Air

  6. Mobile Phones - Is There A Health Risk? Session4. The Role of the Media - Panel Session - Moderator:Paul Jackson, Editor, Microwave Engineering Europe, UK Panellists: Tom Wills-Sandford, FEI, UK Stephen McClelland, Editor, Telecommunications International, UK Nic Fleming, Reporter, Daily Express, UK Simon Best, Editor, Electromagnetic Hazard and Therapy, UK Michaela Reeh, FMK, Austria

  7. International WHO EMF Project Guidelines for Quality EMF Research • The project should test a clearly defined hypothesis • The biological system used should be appropriate to the end-point(s) studied • Only well-characterized biological systems or assays should be used • The number of tests in an experiment should be sufficient to detect reliably the expected size of the effect • A protocol, consistent with Good Laboratory Practice (GLP) guidelines should be established and documented (including symmetric handling of specimens, appropriate controls, blind-study guidelines) • Quality assurance (QA) procedures including dosimetry and monitoring of the programme by an independent group are required

More Related